Tesseract Health
Darius Shahid is an accomplished executive with extensive experience in strategy, growth, and finance. As Chief Strategy Officer at Butterfly Network, Inc. from January 2018 to January 2020, Darius oversaw all aspects of strategy, mergers and acquisitions, corporate development, and business development, achieving over $50 million in revenue through full P&L ownership. Prior roles include Chief Growth Officer at Butterfly Network, Head of Trading at Birch Grove Capital, and a member of the Cross Asset Special Situations Group at Morgan Stanley, specializing in event-driven credit and equity. Darius also has a distinguished background as a professional opera singer with over one hundred performances at the Metropolitan Opera. Education includes a Master of Business Administration from Harvard Business School and a Bachelor of Science from Duke University. Currently, Darius serves as a Board Member at identifeye HEALTH.
This person is not in any teams
This person is not in any offices
Tesseract Health
Tesseract is building a portable, affordable device for monitoring and preventing disease. Tesseract Health is part of the 4Catalyzer accelerator, with over $700 Million in funding, 300 scientists and engineers. Our offices are in Guilford CT, New York City, and Palo Alto. 4Catalyzer is founded by Jonathan Rothberg, the inventor of “Next-Gen” DNA sequencing and ultrasound-on-a-chip (Butterfly Network).